- Home
- WKC vs TNGX Comparison
WKC vs TNGX Comparison
Compare WKC & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WKC | TNGX |
|---|---|---|
| Founded | 1984 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 2.8B |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | WKC | TNGX |
|---|---|---|
| Price | $23.39 | $24.26 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | ★ $28.00 | $20.00 |
| AVG Volume (30 Days) | 560.1K | ★ 2.7M |
| Earning Date | 04-23-2026 | 05-11-2026 |
| Dividend Yield | ★ 3.43% | N/A |
| EPS Growth | N/A | ★ 26.89 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $36,916,600,000.00 | $62,384,000.00 |
| Revenue This Year | $0.62 | N/A |
| Revenue Next Year | $3.42 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 48.29 |
| 52 Week Low | $22.21 | $1.04 |
| 52 Week High | $29.85 | $24.06 |
Technical Indicators
Market Signals| Indicator | WKC | TNGX |
|---|---|---|
| Relative Strength Index (RSI) | 47.20 | 72.59 |
| Support Level | $22.71 | $6.54 |
| Resistance Level | $23.57 | N/A |
| Average True Range (ATR) | 0.50 | 1.37 |
| MACD | 0.11 | 0.14 |
| Stochastic Oscillator | 57.39 | 84.52 |
Price Performance
Historical ComparisonAbout WKC World Kinect Corporation
World Kinect Corp is an energy management company involved in providing supply fulfillment, energy procurement advisory services, and transaction and payment management solutions to commercial and industrial customers. It sells and delivers liquid fuels, natural gas, electricity, renewable energy, and other sustainability solutions. The company operates in three reportable segments consisting of aviation, land, and marine. It earns the majority of its revenue from the Aviation segment.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.